How is my eligibility to a clinical trial determined?

raymond.vanderwaal@mytomorrows.com 11 Jan 2024

1 mins read

share this post

Each clinical trial has specific criteria to determine who can participate. These are called clinical trial eligibility criteria; they help ensure that patients who are participating in a trial are alike.

For example, they may need to have the same type and stage of disease. This helps ensure the trial’s outcomes are the result of the investigational new drug being evaluated. Clinical trial eligibility criteria are also important for the safety of the patient.

myTomorrows does not determine the eligibility of patients but helps with pre-screening them before referring them to a clinical trial. This is only done on broad criteria that are either publicly available or agreed upon with the site (age, location or gender, for instance).

share this post

raymond.vanderwaal@mytomorrows.com 11 Jan 2024

more articles

view all blogs

Whitepaper: Advancing Neuro-Oncology Clinical Trial Access

Daniël Groeneweg

27 Nov 2025

8 mins read

Person with end-stage Parkinson's and caregiver

End-Stage Parkinson’s Disease: Symptoms, Care, and Support

Andrea Enguita

18 Nov 2025

21 mins read

Getting Started: myTomorrows Referral Platform for Site Staff

Adrianne Rivard

14 Nov 2025

10 mins read

myTomorrows Avego finding announcement

Our next chapter: €25M growth investment to scale patient access worldwide

Michel van Harten

11 Nov 2025

7 mins read

ALS patient flow

Accelerating ALS Clinical Trial Recruitment in the U.S.

Dennis Akkaya

10 Oct 2025

12 mins read

Vanessa Lemarie

myTomorrows’ COO Vanessa Lemarié Named in Sifted’s Top 100 Women in Tech Europe

Michel van Harten

10 Oct 2025

2 mins read

Smarter Clinical Trial Recruitment that Delivers Faster Site Enrollment

Dennis Akkaya

18 Sep 2025

10 mins read

Woman with Multiple System Atrophy using a cane to walk

Exploring the Symptoms of Multiple System Atrophy

Andrea Enguita

13 Aug 2025

15 mins read

James Griffin sickle cell patient advocate

Treatment Advances and Patient Advocacy in Sickle Cell Disease: A Conversation with James Griffin

John Massarelli

7 Aug 2025

10 mins read

Searching for Solutions: How Physicians Navigate Trial Access and Technology

Michel van Harten

17 Jul 2025

4 mins read